Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Neuralstem, Inc.
(NY:
CUR
)
1.440
USD
+0.050 (+3.60%)
Official Closing Price
/ Updated:
6:40 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
291,289
Open
1.380
Bid (Size)
1.410 (200)
Ask (Size)
1.520 (500)
Prev. Close
1.390
Today's Range
1.360 - 1.440
52wk Range
0.4200 - 1.960
Shares Outstanding
69,437,694
Dividend Yield
N/A
Top News
More News
President and CEO Publishes New Blog Entitled ''Progress!''
Today 14:20 EDT
from
ACCESSWIRE
Neuralstem ALS Trial Principal Investigator, Dr Eva Feldman, Gives Grand Plenary Address At The Canadian Neurological Sciences Federation Annual Congress
June 10, 2013
Will Present Final ALS Phase I Results Including New Cervical Cohort Data
Read More
from
PR Newswire
More News
Read More
Neuralstem's Cells Induce Improvement In Acute Spinal Cord Injury Rats, UCSD Study Shows
May 28, 2013
from
PR Newswire
Neuralstem (CUR) Files 2.9M Common Shelf for Shareholders
May 28, 2013
from
StreetInsider.com News Articles
Neuralstem Inc. President and CEO Publishes New Blog Entitled ''O brave new world...''
May 22, 2013
from
ACCESSWIRE
Neuralstem Phase I Results Encourage Market, Stimulates Buying
May 21, 2013
category
Bio/Wire
,
CUR
from
Bio-Wire.Com
SmithOnStocks Opines on Stocks May 19, Edition
May 20, 2013
category
A/P/ Pharma Inc/
,
Trius Therapeutics
,
Inc/
, and 11 more.
from
Bio-Wire.Com
Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania
May 20, 2013
from
PR Newswire
Hot Stock: Neuralstem, Shares Gain 6.2% (CUR)
May 16, 2013
from
Comtex SmarTrend® News Briefs
The Early Movers – who’s hot, who’s not
May 16, 2013
category
Henry McCusker
from
Bio-Wire.Com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here